Wooridul Pharmaceutical Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
38,971
44,203
60,405
71,546
79,894
Cost of Goods Sold (COGS) incl. D&A
17,280
20,586
28,301
31,777
38,888
Gross Income
21,691
23,617
32,104
39,769
41,007
SG&A Expense
25,035
27,192
27,534
35,162
35,176
EBIT
3,431
3,610
4,524
4,532
5,710
Unusual Expense
-
30
29
21
125
Non Operating Income/Expense
121
256
1,817
171
62
Interest Expense
384
860
662
511
124
Pretax Income
3,855
4,606
2,153
4,521
6,079
Income Tax
81
25
49
1,031
1,646
Equity in Affiliates
5
40
21
19
-
Consolidated Net Income
3,779
4,621
2,083
3,471
4,433
Net Income
3,699
4,584
2,067
3,452
4,320
Net Income After Extraordinaries
3,699
4,584
2,067
3,452
4,320
Net Income Available to Common
3,699
4,584
2,067
3,452
4,320
EPS (Basic)
470.00
579.00
233.00
364.00
395.00
Basic Shares Outstanding
8
8
9
9
11
EPS (Diluted)
468.94
579.49
233.10
358.28
391.80
Diluted Shares Outstanding
8
8
9
10
11
EBITDA
2,390
2,696
5,346
5,290
6,841
Other Operating Expense
87
35
46
75
120
Non-Operating Interest Income
82
151
80
309
283
Minority Interest Expense
81
37
16
18
113
Equity in Affiliates (Pretax)
-
-
-
-
147
About Wooridul Pharmaceutical
View Profile
